(0.12%) 5 303.27 points
(0.34%) 40 004 points
(-0.07%) 16 686 points
(0.97%) $80.00
(5.73%) $2.64
(1.44%) $2 419.80
(6.36%) $31.78
(2.18%) $1 094.70
(-0.02%) $0.920
(-0.18%) $10.68
(-0.27%) $0.787
(0.19%) $91.05
Live Chart Being Loaded With Signals
Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China...
Stats | |
---|---|
Today's Volume | 1 837.00 |
Average Volume | 7 919.00 |
Market Cap | 227.74M |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.830 |
ATR14 | $0.360 (2.72%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2009-03-16 | Blatz Robert G | Buy | 0 | |
2009-02-18 | Blatz Robert G | Sell | 242 547 | Common Stock, par value $.01 |
2009-02-18 | Considine Terry | Sell | 83 079 | Common Stock, par value $.01 |
2009-02-18 | Rhodes Thomas L | Sell | 92 328 | Common Stock, par value $0.01 |
2008-12-31 | Considine Terry | Sell | 5 000 | Common Stock, par value $.01 |
INSIDER POWER |
---|
0.00 |
Last 97 transactions |
Buy: 1 786 556 | Sell: 1 688 226 |
Adlai Nortye Ltd. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Adlai Nortye Ltd. Financials
Annual | 2023 |
Revenue: | $5.00M |
Gross Profit: | $2.78M (55.56 %) |
EPS: | $-2.42 |
FY | 2023 |
Revenue: | $5.00M |
Gross Profit: | $2.78M (55.56 %) |
EPS: | $-2.42 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-2.04M (0.00 %) |
EPS: | $-0.600 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Adlai Nortye Ltd.
Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China. Its lead product is AN2025, a pan-phosphoinositide 3-kinase inhibitor, which is in Phase III clinical trial for the treatment of recurrent or metastatic head and neck squamous cell carcinomas. The company is also developing AN0025, a small molecule EP4 antagonist to modulate the tumor microenvironment; and AN4005, an oral small-molecule PD-L1 inhibitor to induce and stabilize PD-L1 dimerization and thereby disrupt the interaction between PD-1 and PD-L1. Its preclinical candidates include AN8025, a multifunctional antibody as T cell and APC modulator; AN1025, an oral small molecule degrader of ß-catenin; and AN9025, an oral small molecule pan-KRAS inhibitor. The company was incorporated in 2018 and is based in Grand Cayman, the Cayman Islands.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators